Literature DB >> 15810986

Differential regulation of angiotensin II receptors during renal injury and compensatory hypertrophy in the rat.

Emma Joly1, Denis Nonclercq, Nathalie Caron, Jeannine Mertens, Bruno Flamion, Gerard Toubeau, Ronald Kramp, Nadine Bouby.   

Abstract

1. The renin-angiotensin system may be involved in the compensatory adaptations occurring after the reduction of renal mass and during the consecutive changes leading to chronic renal failure. We therefore investigated the regulation of angiotensin II receptors in two models of renal hypertrophy in the rat: hypertrophy following uninephrectomy (UNx) or subtotal nephrectomy (STNx). The level of angiotensin type 1 (AT1A-R and AT1B-R) and type 2 (AT2-R) receptor mRNA was quantified by competitive reverse transcription-polymerase chain reaction (RT-PCR) in specific renal zones and the intrarenal distribution of angiotensin II receptors was analysed by immunohistochemistry. 2. In the UNx rats, AT1-R mRNA expression was not modified in the cortex or in the inner stripe of the outer medulla of the residual kidney at any time after the surgery (1, 4 and 12 weeks). In contrast, AT1-R mRNA expression was significantly reduced in these zones in STNx rats (-33% and -40%, respectively). This downregulation was organ-specific, as AT1-R mRNA levels were not modified in the liver. The proportions of AT1-R subtype (AT1A and AT1B) mRNA were unchanged by UNx or STNx. Very low levels of AT2-R mRNA were found in the cortex of all groups. Immunostaining revealed a similar localization of AT1-R in mesangial cells, proximal tubule, basolateral membrane of thick ascending limb, in both models of hypertrophy. AT1-R labelling was also detected in the apical membrane of intercalated cells of cortical collecting ducts. 3. This differential mRNA expression of angiotensin II receptors during compensatory hypertrophy and renal injury suggests that the development of renal hypertrophy is independent of AT1-R and AT2-R gene expression levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15810986     DOI: 10.1111/j.1440-1681.2005.04181.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  5 in total

1.  Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin.

Authors:  Jill W Verlander; Seongun Hong; Vladimir Pech; James L Bailey; Diana Agazatian; Sharon W Matthews; Thomas M Coffman; Thu Le; Tadashi Inagami; Florence M Whitehill; I David Weiner; Donna B Farley; Young Hee Kim; Susan M Wall
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-14

2.  The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan.

Authors:  Ehécatl Miguel Ángel García Trejo; Abraham Said Arellano Buendía; Omegar Sánchez Reyes; Fernando Enrique García Arroyo; Raúl Arguello García; María Lilia Loredo Mendoza; Edilia Tapia; Laura Gabriela Sánchez Lozada; Horacio Osorio Alonso
Journal:  Int J Mol Sci       Date:  2017-09-16       Impact factor: 5.923

3.  Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.

Authors:  Basma Ismail; Rob A deKemp; Etienne Croteau; Tayebeh Hadizad; Kevin D Burns; Rob S Beanlands; Jean N DaSilva
Journal:  PLoS One       Date:  2017-05-19       Impact factor: 3.240

4.  Decreased renal AT1 receptor binding in rats after subtotal nephrectomy: PET study with [(18)F]FPyKYNE-losartan.

Authors:  Basma Ismail; Robert A deKemp; Tayebeh Hadizad; Kumiko Mackasey; Rob S Beanlands; Jean N DaSilva
Journal:  EJNMMI Res       Date:  2016-06-23       Impact factor: 3.138

5.  Dysregulation of microRNAs and renin-angiotensin system in high salt diet-induced cardiac dysfunction in uninephrectomized rats.

Authors:  Venkateswara Rao Amara; Sunil Kumar Surapaneni; Kulbhushan Tikoo
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.